Abbott Laboratories Stock
€77.76
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Abbott
sharewise wants to provide you with the best news and tools for Abbott, so we directly link to the best financial data sources.
Financials
News
Abbott Stock Crash: Rebound Could Be Coming Fast
Abbott Laboratories' (NYSE: ABT) share price corrected by approximately 45% from peak to trough, bottoming in early Q2 2026 after reaching incredibly oversold levels.
While there is cause for this
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?
In the world of investing, stability is a prized commodity. Few companies embody that stability better than Abbott Laboratories (NYSE: ABT), a diversified healthcare powerhouse and a member of the
Is Abbott’s January Pullback a Good Time to Buy?
Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a
2 Healthcare Names That Could Get a Big Boost From Earnings
Active traders expect companies in the healthcare sector to experience significant share price spikes tied to milestones in the development of new therapies and medical products. The volatility in
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one another in the market for continuous glucose monitoring (CGM) systems.
Why Abbott Laboratories Stock Tumbled on Thursday
Abbott Laboratories (NYSE: ABT) more or less met analyst estimates in its first quarter, the results of which were published early Thursday morning. This clearly wasn't good enough for investors, as
3 Healthcare Stocks That Have Held Up in Every Market Downturn
Economic downturns cast a wide net across the market, and there's no stock that's completely immune to a recession. However, certain income-oriented healthcare stocks can help investors weather
Best Healthcare Stocks to Buy Right Now for Long-Term Growth
Stocks that perform well over the long run tend to have several traits, such as a large, growing market where they have a strong presence, solid financial results, and a competitive moat. Investing
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now
Abbott Laboratories (NYSE: ABT), a medical device specialist, recently fell off a cliff after a disappointing quarterly update that missed consensus top-line estimates. The healthcare giant is
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich
Over the past few years, the exciting field of artificial intelligence (AI) has captured much of Wall Street's attention and headlines. And sure enough, some of the leaders in AI have produced
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever
You may not immediately recognize the name Abbott Laboratories (NYSE: ABT), but you've probably come into close contact with one of the company's many products -- from a coronavirus test to Ensure
The Best Dividend King to Buy With $150
Shares of Abbott Laboratories (NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away
3 Reasons to Buy This Dividend King After Its Steep Sell-Off
Abbott Laboratories (NYSE: ABT) announced its 2025 fourth-quarter and full-year results before the market opened on Thursday, Jan. 22, 2026. And its shares promptly plunged nearly 10%. As you
2 Healthcare Stocks to Buy in a Bear Market
It might not seem like it, but the S&P 500 flirted with bear market territory earlier this year. It has rebounded nicely since, but it's always worth considering which stocks would be worth buying
2 Dividend Stocks to Buy for 2026 and Beyond
No one knows how the stock market will unfold in 2026. Perhaps broader equities will experience significant volatility but perform well by the end of the year, just as they seem to be doing in 2025
This Top Dividend King Just Became an Even Better Buy
Abbott Laboratories (NYSE: ABT), a medical device specialist, has a lot going its way. The company has a large and diversified portfolio of products, which it routinely expands through new launches
Why Exact Sciences Stock Surged Today
Shares of Exact Sciences (NASDAQ: EXAS) climbed on Thursday after the medical diagnostics specialist agreed to be acquired by Abbott (NYSE: ABT) for $21 billion.
As of 2:30 p.m. EST, Exact
Why Exact Sciences Stock Blasted Nearly 24% Higher Today
News of an apparently impending sale to a strategic investor sent shares of Exact Sciences (NASDAQ: EXAS) skyward on Wednesday. The cancer diagnostics specialist's shares closed the day nearly 24%